Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Long-Term Care Proposal Draws Opposition
The insurance industry opposes a long-term care proposal called the CLASS Act, currently included in two major health care reform measures.
generic viagra online
Siemens Launches 'Decibels For Life' - New Campaign Aims For Hearing Awareness And Instrument Innovation
"Decibels for Life", the new campaign from Siemens Hearing Instruments, has been launched to maintain awareness of hearing loss. It will also champion hearing innovations that help overcome impairments leading to an improved quality of life.
News of the day
Why Is It Important To Get A Second Opinion For A Total Knee Replacement?
While total knee surgery is a common procedure with a high success rate in the US, getting a second opinion is still recommended. Each surgeon has had a specific training and education, and more experience with certain procedures over others. Some surgeons embrace new technologies and methods while others are more traditional in their practice. Furthermore, you want to feel comfortable with your surgeon. Taking the additional steps to research, interview, and visit more than one doctor can pay off in the long run.
Medical Devices

UCB's CIMZIA(R) (certolizumab Pegol) Approved By The U.S. FDA For Adult Patients Suffering From Moderate To Severe Rheumatoid Arthritis

UCB announced that the U.S. Food and Drug Administration (FDA) approved Cimzia®, the only PEGylated anti-TNF (Tumor Necrosis Factor), for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA). Cimzia® can be dosed at 400 mg initially and at weeks two and four, followed by 200 mg every other week; for maintenance dosing, 400 mg every four weeks can be considered. In clinical trials with Cimzia®, together with methotrexate (MTX), patients experienced a significant reduction in the signs and symptoms of RA at week 24 with some showing clinical responses within one to two weeks, compared with MTX alone. Additionally, radiographic data showed Cimzia®, together with MTX, inhibited progression of joint damage, with a significantly smaller change from baseline in modified Total Sharp Score (TSS) at 24 and 52 weeks of treatment, compared with MTX alone (p CIMZIA


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009